This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Rasu Shrestha, Chief Innovation Officer of UPMC and VP of UPMC Enterprises, the entrepreneurial division of the University of Pittsburgh Medical Center. Dr. Shrestha is also Co-Chair of Health Datapalooza, and discusses the need for design thinking and building a culture of innovation to truly transform the health care system.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Eric Topol, renowned cardiologist, geneticist, digital health advocate, and founder of the Scripps Translational Science Institute. They discuss his work developing technologies for the “All of Us” precision medicine campaign at NIH, and the efforts still needed to support true precision medicine initiatives in American health care.
This week, hosts Mark Masselli and Margaret Flinter speak with Pulitzer Prize winning Wall Street Journal reporter John Carreyrou, author of “Bad Blood: Secrets and Lies in a Silicon Valley Startup,” a riveting account of the scandal he uncovered at Theranos, a health tech startup that promised to revolutionize diagnostic testing. Mr. Carreyrou uncovered company founder Elizabeth Holmes’ widespread deception that duped high level investors and put patients’ lives at risk.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Aviv Regev of the Broad Institute of MIT and Harvard, and Dr. Sarah Teichmann of the Wellcome Sanger Institute at Cambridge, Co-Chairs of the Human Cell Atlas project which is seeking to create a “Google Maps” for the body’s 37 trillion cells. It’s a global collaboration of multiple scientific disciplines, tasked with creating a comprehensive and open-source cell map, to yield a deeper understanding of the foundational elements of…
This week hosts Mark Masselli and Margaret Flinter speak with Dr. Ashish Jha, Associate Dean for Research Translation and Global Strategy at Harvard T.H. Chan School of Public Health. They discuss his recent report analyzing American health care costs compared to 10 other industrialized nations pointing to lack a of data and price transparency as drivers, suggesting that a combination of public policy and private innovations will lead to an “American solution” to the cost problem.
This week, hosts Mark Masselli and Margaret Flinter speak with Peter O’Neill, Executive Director of Cleveland Clinic Innovations, the commercialization branch of Cleveland Clinic dedicated to bringing clinicians’ inventions to the marketplace. Mr. O’Neill discusses the system that supports the clinicians/inventors, Cleveland Clinic’s global expansion, and their annual list of technologies that will disrupt health care.